Recovery & Tissue Repair
Repair claims organized by human evidence, model system, product identity, and route.
ASK BETTER QUESTIONS
What changes a recovery & tissue repair evidence decision?
- Is the evidence human or preclinical?
- Does the study use the same molecule and formulation?
- Are recovery claims attached to a defined clinical endpoint?
EVIDENCE RECORDS
Recovery & Tissue Repair evidence records.
BPC-157
Interest in BPC-157 is driven by broad preclinical findings. The central evidence gap is not whether animal signals exist, but whether a defined product is safe and effective in people.
Open evidence recordTB-500
The first question for TB-500 is entity identity: evidence about full-length thymosin beta-4 should not be treated as direct evidence for every TB-500 product.
Open evidence recordThymosin Beta-4
Thymosin beta-4 has early human development work and extensive preclinical biology, but that record does not establish routine systemic recovery use or equivalence to TB-500 products.
Open evidence recordGHK-Cu
GHK-Cu is biologically active and has limited topical human research, but the evidence does not validate broad injectable, systemic, or anti-aging claims.
Open evidence recordDIRECT COMPARISONS